CSD190101: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jason Hong, MD
RAIS
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Woodland Research Northwest, Llc
Rogers, Arkansas, United States
- Central Kentucky Research
Lexington, Kentucky, United States
- Qps Bio-Kinetic
Springfield, Missouri, United States
- High Point Clinical Trials Center
High Point, North Carolina, United States
- New Orleans Center for Clinical Research (noccr)
Knoxville, Tennessee, United States
- Spaulding Clinical Research, Llc
West Bend, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Jul 2019
- Primary completion
- 31 Aug 2019
- Completion
- 31 Aug 2019
- Last update posted
- 25 Oct 2019
- Registered enrollment
- 64
- Registry id
- NCT03993769
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.